Voyager Therapeutics appoints ex-Biogen EVP Alfred Sandrock to board, names Robin Swartz COO

Voyager Therapeutics, Inc.

Alfred Sandrock, former Biogen EVP R&D, appointed to Board effective Feb 7, 2022; consulting agreement at $30k/month.
Robin Swartz promoted to COO; base salary $420k, target bonus 40%, and option grant of 65,000 shares.
Sandrock receives standard director compensation: $40k annual cash, initial option for 44,000 shares, plus committee fees.
Swartz's employment extends COBRA premium payments to 12 months on qualifying termination.
Both appointments effective Feb 7, 2022; Sandrock's term runs until 2023 annual meeting.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Alfred Sandrock, M.D., Ph.D.

director

VYGR · Voyager Therapeutics, Inc.

Effective: 2022-02-07
Filed: February 3, 2022, 6:59 PM ET

appointed Alfred Sandrock, M.D., Ph.D. as a director of the Company and as a member of both the Executive Committee and the Science and Technology Committee of the Board, effective February 7, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Alfred Sandrock, M.D., Ph.D. was appointed as director at Voyager Therapeutics, Inc..

Action: appointed
Role: director

Exact text from the filing

appointed Alfred Sandrock, M.D., Ph.D. as a director of the Company and as a member of both the Executive Committee and the Science and Technology Committee of the Board, effective February 7, 2022.

View on SEC.gov

Voyager Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-011398

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.